This Nov 3rd, join us for the third edition of Business of Cannabis: New York at the New York Academy
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at the New York Academy
As reported by Cannareporter. Avextra will move forward with a double-blind Phase 2 clinical trial for the use of cannabis in
Cantourage Group SE (hereinafter “Cantourage,” ISIN: DE000A3DSV01, www.cantourage.com), a leading European company for the production and distribution of medical cannabis,
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at the New York Academy
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel. A
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel. A
Curaleaf Holdings has confirmed it has filed its application to list its subordinate voting shares on the Toronto Stock Exchange (TSX).
Swiss cannabis management software company Cannavigia, whose product is currently being utilised by cultivators and across the Swiss pilot programmes,
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel. A
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.